Hyam Levitsky Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Hyam Levitsky.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Hyam Levitsky. Hyam Levitsky is Director in AGENUS INC ($AGEN) and EVP, Research & CSO in Juno Therapeutics, Inc. ($JUNO) and See Remarks in Juno Therapeutics, Inc. ($JUNO) and Director in Replimune Group, Inc. ($REPL).
Latest Insider Trading Transactions of Hyam Levitsky
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGEN, JUNO, REPL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | REPL | Replimune Group, I ... | Levitsky Hyam | Director | Option Exercise | A | 31.58 | 16,500 | 521,070 | 16,500 | |
| Apr 02 2020 | REPL | Replimune Group, I ... | Levitsky Hyam | Director | Option Exercise | A | 9.78 | 16,500 | 161,370 | 16,500 | |
| Apr 03 2019 | REPL | Replimune Group, I ... | Levitsky Hyam | Director | Option Exercise | A | 15.50 | 13,500 | 209,250 | 13,500 | |
| Jul 26 2018 | REPL | Replimune Group, I ... | Levitsky Hyam | Director | Option Exercise | A | 15.00 | 27,000 | 405,000 | 27,000 | |
| Feb 09 2017 | JUNO | Juno Therapeutics, ... | Levitsky Hyam | EVP, Research & CSO | Option Exercise | A | 20.76 | 68,182 | 1,415,458 | 68,182 | |
| Feb 09 2017 | JUNO | Juno Therapeutics, ... | Levitsky Hyam | EVP, Research & CSO | Grant | A | 0.00 | 14,634 | 0 | 131,334 | 116.7 K to 131.3 K (+12.54 %) |
| Jun 21 2016 | JUNO | Juno Therapeutics, ... | Levitsky Hyam | EVP, Research & CSO | Sell | S | 43.20 | 300 | 12,960 | 116,700 | 117 K to 116.7 K (-0.26 %) |
| Jun 21 2016 | JUNO | Juno Therapeutics, ... | Levitsky Hyam | EVP, Research & CSO | Sell | S | 42.76 | 12,118 | 518,121 | 117,000 | 129.1 K to 117 K (-9.39 %) |
| May 27 2016 | JUNO | Juno Therapeutics, ... | Levitsky Hyam | EVP, Research & CSO | Payment of Exercise | F | 42.04 | 16,454 | 691,726 | 129,118 | 145.6 K to 129.1 K (-11.30 %) |
| Feb 04 2016 | JUNO | Juno Therapeutics, ... | Levitsky Hyam | See Remarks | Option Exercise | A | 24.50 | 100,000 | 2,450,000 | 100,000 | |
| Jun 01 2015 | JUNO | Juno Therapeutics, ... | Levitsky Hyam | See Remarks | Option Exercise | A | 50.60 | 175,000 | 8,855,000 | 175,000 | |
| Jun 01 2015 | JUNO | Juno Therapeutics, ... | Levitsky Hyam | See Remarks | Grant | A | 0.00 | 145,000 | 0 | 145,000 | 0 to 145 K |
| Jun 11 2007 | AGEN | AGENUS INC | Levitsky Hyam | Director | Option Exercise | A | 3.02 | 15,000 | 45,300 | 40,000 |
Page: 1